Akiva Diamond

Akiva Diamond, M.D. is an Assistant Professor in the Hematology & Oncology department at Baylor College of Medicine, Houston, Texas. He specializes in clinical research for hematologic malignancies and oncology, with a focus on geriatric populations and treatment-related complications.

• Education: M.D. from University of Maryland School of Medicine (2014)
• Residency: Case Western Reserve University / University Hospitals Cleveland Medical Center (2017)
• Fellowship: Internal Medicine and Hematology/Oncology at Case Western Reserve University (2020)

His research addresses clinical challenges in elderly cancer patients, including:

• Immune checkpoint inhibitor toxicity in patients aged ≥80 years
• Survival outcomes in elderly DLBCL patients
• Cardiovascular risks associated with anthracycline and ibrutinib therapies
• Age-related decision-making in CLL clinical trials
• Hypercoagulability in COVID-19 patients

Recent publications highlight his work on treatment efficacy, toxicity profiles, and real-world data from multicenter studies. He is affiliated with the Dan L Duncan Comprehensive Cancer Center, contributing to clinical care and translational research in hematologic cancers.